It looks like Daiichi Sankyo is making the move.
Why keep on paying royalty when you can buy several drug patents for $200 mil less 70mil cash ?
It looks like Daiichi Sankyo is making the move. Why keep on...
Add to My Watchlist
What is My Watchlist?